To be specific, Popoli and co-workers showed that A2AR activation could restore mitochondrial membrane potential and cholesterol accumulation alterations in NPC1 patient fibroblasts and human neuronal and oligodendroglial NPC1 cell lines, suggesting a potential therapeutic role for A2AR in the treatment of this rare genetic disorder [36,37]. This evidence concerns the gene NPC1 and hereditary disease.